Cargando…
Correction: Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems
Autores principales: | Roy Chowdhury, Uttio, Bahler, Cindy K., Holman, Bradley H., Dosa, Peter I., Fautsch, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684394/ https://www.ncbi.nlm.nih.gov/pubmed/26669304 http://dx.doi.org/10.1371/journal.pone.0144791 |
Ejemplares similares
-
Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems
por: Roy Chowdhury, Uttio, et al.
Publicado: (2015) -
Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents
por: Roy Chowdhury, Uttio, et al.
Publicado: (2017) -
ATP-sensitive potassium (K(ATP)) channel openers diazoxide and nicorandil lower intraocular pressure by activating the Erk1/2 signaling pathway
por: Roy Chowdhury, Uttio, et al.
Publicado: (2017) -
Effect of ATP-sensitive Potassium Channel Openers on Intraocular Pressure in Ocular Hypertensive Animal Models
por: Roy Chowdhury, Uttio, et al.
Publicado: (2022) -
Ocular Hypotensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (K(ATP)) Channel Opening Prodrug
por: Pervan-Steel, Cynthia L., et al.
Publicado: (2022)